Postoperative use of the chemopreventive vitamin K2 analog in patients with hepatocellular carcinoma.
<h4>Aim</h4>To evaluate the chemopreventive efficacy of vitamin K2 (VK2) analog in patients with hepatocellular carcinoma (HCC) after curative hepatic resection or local ablation, since a recent randomized control trial (RCT) and systematic review have given contradictory results.<h4&...
Guardado en:
Autores principales: | Jian-Hong Zhong, Xin-Shao Mo, Bang-De Xiang, Wei-Ping Yuan, Jin-Fang Jiang, Gui-Sheng Xie, Le-Qun Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d68bf9e1c45f430bac18b6bbf9b63b4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
por: Jian-Hong Zhong, et al.
Publicado: (2013) -
Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
por: Yang Yang, et al.
Publicado: (2021) -
Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.
por: Jian-Hong Zhong, et al.
Publicado: (2013) -
Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4
por: Xin Lu, et al.
Publicado: (2021) -
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma.
por: Ya-Hui Huang, et al.
Publicado: (2012)